Registration and Networking
Welcome and Opening Remarks
Talk 1: Re-Imagining clinical research
Talk 2: Advancing clinical trials through tech collaborationLeveraging new tech tools for clinical trials, including tablets, mobile technology, mHealth, apps, wearables, sensors, digital biomarkers, digital technology and social media.
Talk 3: Validating digital tech for clinical trials
Partner, Syncona Investment Management Ltd
Coffee and Networking Break
Case Study: Ensuring success with patient-centric approaches to patient recruitment and site selectionIn this session, we will cover best practices and a case study on successful patient engagement, recruitment and site selection techniques using novel, patient-centric and data-driven approaches.
Talk 4: Technology for bringing clinical trials into the home/remote trials
Global Head, Patient Affairs and Policy, Chief Medical Office, Novartis (US)
Talk 5: Clinical research in the age of social mediaHarnessing online social networks, social media, mHealth, patient registries, EMRs and Big Data, patient communities, physician communities to support recruitment, retention, and engagement.
Discussion 1: Internet of Things in clinical trials: Challenges, opportunities and the critical missing features to fully leverage the digital revolution• What is slowing the digital revolution? (such as user engagement, “pilot-itis”, lack of data validity)
• The challenges of managing IoT in digital health (such as data correlation with clinical significance etc)
Lunch and Networking Break
Talk 6: Building an end-to-end strategy for patient engagementIncluding, how data transparency in clinical trials can transform patient recruitment and engagement.
CEO, RxPrism Health Systems
Talk 7: Navigating the legal environment when processing patient Data – Privacy vs transparency
Public Policy at Niti Aayog, Office of Vice Chairman, Niti Aayog, Government of India
Talk 8: Making meaningful, data-driven decisions in clinical trialsAs new technology and increasing volumes of data become more accessible to the biopharmaceutical industry, how will the industry make meaningful, data-driven decisions aimed at improving the clinical trial process? This talk will include aggregating, integrating and mining existing data sources (biomarkers, genomic, imaging, EHRs, PHR, claims data, public data sets such as clinicaltrials.gov and real-world data) to aid in clinical development.
Coffee and Networking Break
Talk 9: Holograms, AI and “lab-tags”: The future of clinical trials?
Discussion 2: What do you think is the future of clinical trials?AI, mHealth, IoT, big data, social media; there's no doubt that technology is changing clinical trials. However, everyone has different ideas about how best to use these technologies and where they are taking the trials of the future. Additionally, with innovative trial designs, increasingly patient-centric approaches, biomarkers and personalised medicine, clinical trials could look very different in 5, 10 or 20 years.
Global Head Patient and Stakeholder Engagement, UCB